Key result
Percutaneous echo-guided radiofrequency ablation safely reduces tumor size and improves symptoms in canine chemodectomas.
Why the study?
Chemodectomas have complex clinical management and can cause pericardial effusion or compression, prompting the exploration of percutaneous echo-guided radiofrequency ablation.
Does percutaneous echo-guided radiofrequency ablation improve clinical signs and reduce tumor size safely in dogs with chemodectomas?
Case Report (n=5)
Does percutaneous echo-guided radiofrequency ablation improve clinical signs and reduce tumor size safely in dogs with chemodectomas?
Answers are grounded in this paper and cite their sources.
Percutaneous echo-guided radiofrequency ablation appears to be a feasible and safe minimally invasive treatment for dogs with chemodectomas causing severe clinical compromise.
Chemodectomas are low prevalence tumors with complex clinical management. Many present as an incidental finding however, in other dogs, they produce pericardial effusion and/or compression, leading to the appearance of severe clinical signs. There are currently several approaches: surgery, radiotherapy, stent placement and chemotherapy. This is the first description of percutaneous echo-guided radiofrequency ablation of aortic body tumors. This minimally invasive treatment is based on high frequency alternating electrical currents from an electrode that produces ionic agitation and generates frictional heat, causing coagulation necrosis. Five dogs with an echocardiographic and cytological diagnosis of chemodectoma underwent percutaneous echo-guided radiofrequency ablation. At the time of presentation, all the dogs showed clinical signs, such as ascites and/or collapse. There were no complications either during the procedure or in the following 24 hours. Rapid clinical improvement associated with a reduction in size and change in sonographic appearance of the mass were achieved with no complications. Six months follow-up was carried out in all dogs. A second percutaneous echo-guided RFA was performed eight months after the first procedure in one dog. Based on our experience, radiofrequency ablation seems to be a feasible and safe technique, making it a potential alternative therapeutic approach in the clinical management of aortic body tumors leading to severe clinical compromise.
No takes yet. Share an insight, caveat, or question.
Ochoa et al. (2021) conducted a case report in Chemodectoma (aortic body tumors) (n=5). Percutaneous echo-guided radiofrequency ablation was evaluated on Clinical improvement, reduction in tumor size, and procedural complications. Percutaneous echo-guided radiofrequency ablation was feasible and safe in 5 dogs with chemodectomas, achieving rapid clinical improvement and tumor size reduction without complications.
Synapse has enriched 10 related papers. Consider them for comparative context: